DUBLIN, April 4, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/dcrm2k/pediatric) has announced the addition of the "Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device & Procedures - Global Forecasts to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
In the recent years, the pediatric interventional cardiology market has witnessed a large number of technological advancements, owing to which new and advanced products are being launched in the market. The global market was valued at $894.7 million in 2013 and is expected to reach $1,379.1 million by 2018, at a CAGR of 9.0%. The market is broadly classified based on the type of devices and geography. The number of pediatric interventional cardiology procedures performed in each geography are also provided in this report.
The devices market is further divided into structural heart defect closure devices, transcatheter heart valves, and Others. The structural heart defect closure devices segment is sub-divided into artial septal defect closure devices, ventricular septal defect closure devices, patent foramen ovale, patent ductus arteriosus, and left artial appendage closure devices. The transcatheter heart valves segment is classified into transcatheter pulmonary valves and transcatheter aortic valves. The Others segment consist of devices such as catheters, guidewires, stents, and balloons.
The major factors driving the growth of the market include the growth in government support, rising incidences of congenital heart defects, technological advancements, and the advantages of minimally invasive surgeries over traditional surgeries. Moreover, the presence of a large untapped market in emerging countries, high growth potential of transcatheter heart valves market, and advancements in biodegradable devices for pediatric patients represent the growth opportunities for this market. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures are the factors that are curbing the growth of this market.
The global market is dominated by Europe, followed by North America, APAC, and the Rest of the World (RoW). Over the next five years, the growth of the global market in the APAC region is likely to be centered at China, Japan, Australia, New Zealand, Singapore, and India. This growth will be driven by new product launches, government initiatives, and investments by major players in the APAC market. The major players in the pediatric interventional cardiology market include St. Jude Medical, Inc. (U.S.), Medtronic, Inc. (U.S.), W.L. Gore & Associates, Inc. (U.S.), Edwards Lifesciences Corp (U.S.), NuMED, Inc. (U.S.), Cordis Corporation (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Boston Scientific (U.S.), and Abbott Vascular (U.S.), among others.
Key Topics Covered:
1 Introduction
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Pediatric Interventional Cardiology Procedures
6 Pediatric Interventional Cardiology Devices Market
7 Geographic Analysis
8 Competitive Landscape
9 Company Profiles
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/dcrm2k/pediatric
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article